The first patient is an adult male with early-onset parkinsonism and comorbid neuropsychiatric disease, for whom we used single-photon emission CT (SPECT) scans to reveal a progressive loss of DAT availability. This evidence concerns the gene SLC6A3 and Parkinsonism.